Hidden Prostate Cancer Patterns That Predict Deadly Disease Are Being Missed in Biopsies
A new Nature Reviews Urology review warns that intraductal and invasive cribriform prostate cancers are aggressive, genomically unstable and frequently ...
Tag: PARP inhibitors
Platinum Chemotherapy, Not PARP Inhibitors, Emerges as the Main Driver of Blood Clone Expansion
New research shows carboplatin drives the expansion of TP53-mutant blood clones far more strongly than PARP inhibitors, while inherited homologous ...
Huntsman Cancer Institute Names Theresa Werner Chief of Oncology Division
Theresa Werner, MD, a gynecologic oncologist and veteran clinical trials leader, has been named chief of the Division of Oncology ...
CA-125 and RECIST: Key Insights in Ovarian Cancer
Recent advancements in the treatment of ovarian cancer have increasingly focused on understanding the recurrent patterns of the disease and ...
Organoids Forecast Chemotherapy, PARP Inhibitor Outcomes in Ovarian Cancer
In a groundbreaking study that could reshape the treatment landscape for advanced ovarian cancer, researchers have successfully utilized patient-derived organoids ...
New Blood Test Paves the Way for More Effective Ovarian Cancer Treatments
Every year, more than 300,000 women worldwide receive the devastating diagnosis of ovarian cancer, a disease notorious for its complexity ...
Optimized Tumor Therapy: Phase I Trial of Gapped Scheduling
In a groundbreaking development that could redefine cancer therapy, researchers have unveiled a novel approach to delivering topoisomerase I (top1) ...
Ovarian cancer discovery: targetable variant RAD51D found in Chinese patients
Researchers from BGI Genomics and Fudan University published new findings on OV among Chinese patients in JCO Global Oncology. The ...
POPULAR NEWS
-
Rural Residence Linked to Higher Gut Microbiome Diversity in Older Portuguese Adults
-
Mechanical Roll Hardening Produces Deep Subsurface Compressive Stresses in Steel Gear Journals
-
Integrated Sensor Platform Authenticates Commercial Boju Chrysanthemum Cultivars
-
Midline Catheters Show Lower Infection Risk in ICU Patients